Should I Buy IBRX Stock in 2026?
Data-driven analysis and honest assessment for Immunitybio Inc
Current Price: $7.25
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
P/E data not available
Slow growth of 2%
Profitability data limited
Financial health data limited
Negative free cash flow
No recent insider activity
Key Investment Metrics
Current Price
$7.25
P/E Ratio
N/A
Revenue Growth
4.1%
Profit Margin
N/A
Market Cap
$8.0B
Dividend Yield
None
How IBRX Compares to Competitors
Understanding how IBRX stacks up against peers helps inform your investment decision.
How IBRX Compares to Peers
Upcoming Events for IBRX
+5 Reasons TO Buy IBRX
1. High gross margins of 99%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy IBRX
1. Negative free cash flow
high riskBurning cash creates funding risk and limits shareholder returns.
Who Should Buy IBRX?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 4% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in IBRX, compare these Health Care peers:
Pro tip: Compare IBRX directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for IBRX
Frequently Asked Questions
What is IBRX stock price today?
IBRX (Immunitybio Inc) stock is trading at $7.25 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is IBRX stock going up or down today?
IBRX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy IBRX stock now?
The decision to buy IBRX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is IBRX a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for IBRX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is IBRX stock overvalued or undervalued?
Use our DCF valuation calculator to determine if IBRX is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is IBRX's P/E ratio?
P/E ratio data for IBRX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is IBRX's market cap?
IBRX (Immunitybio Inc) has a market capitalization of $8.03 billion, making it a small-cap stock.
What is IBRX's price to book ratio?
Price-to-book ratio for IBRX is available on our dashboard along with other valuation metrics.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Immunitybio Inc
Full Stock Analysis
Complete IBRX overview with charts and data
Is IBRX Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how IBRX stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Immunitybio Inc
Complete IBRX Analysis
Compare IBRX With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.